[1. Han JC, Lawlor DA, Kimm YS. Childhood Obesity. Lancet. 2010;375(9727):1737-48. DOI: 10.1016/S0140-6736(10)60171-710.1016/S0140-6736(10)60171-7]Open DOISearch in Google Scholar
[2. De Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92(5):1257–64. DOI: 10.3945/ajcn.2010.2978610.3945/ajcn.2010.29786]Open DOISearch in Google Scholar
[3. Chirita-Emandi A, Barbu CG, Cinteza EE, Chesaru BI, Gafencu M, Mocanu V, et al. Overweight and Under-weight Prevalence Trends in Children from Romania – Pooled Analysis of Cross-Sectional Studies between 2006 and 2015. Obes Facts. 2016;9(3):2016-20. DOI: 10.1159/00044417310.1159/000444173]Open DOISearch in Google Scholar
[4. NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018;0:1–21 in press.]Search in Google Scholar
[5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, over-weight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. DOI: 10.1016/S0140-6736(17)32129-310.1016/S0140-6736(17)32129-3]Open DOISearch in Google Scholar
[6. Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M et al. The Science of Obesity Management: an Endocrine Society Scientific Statement. Endocr Rev 2018;39:1-54. DOI: 10.1210/er.2017-0025310.1210/er.2017-00253588822229518206]Open DOISearch in Google Scholar
[7. Levy E, Saenger AK, Steff MW, Delvin E. Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers. EJIFCC 2017;28(1):6-24.]Search in Google Scholar
[8. Zhu ZL, Yang QM, Li C, Chen J, Xiang M, Chen MM et al. Identification of biomarkers for childhood obesity based on expressional correlation and functional similarity. Mol Med Rep. 2018;17(1):109-16.10.3892/mmr.2017.7913]Search in Google Scholar
[9. Sikaris KA. The Clinical Biochemistry of Obesity. Clin Biochem Rev. 2004;25(3):165-81.]Search in Google Scholar
[10. Socha P, Hellmuth C, Gruszfeld D, Demmelmair H, Rzehak P, Grote V, et al. Endocrine and Metabolic Biomarkers Predicting Early Childhood Obesity Risk. Nestle Nutr Inst Workshop Ser. 2016;85:81-8. DOI: 10.1159/00043948910.1159/00043948927088335]Search in Google Scholar
[11. Cinteza M - Can we Cure Type 2 Diabetes Mellitus? Maybe Yes !...- Maedica (Bucharest). 2013 Sep;8(3):229-30.]Search in Google Scholar
[12. Venner AA, Lyon ME, Doyle-Baker PK. Leptin: a Potential Biomarker for Childhood Obesity? Clin Biochem. 2006 Nov;39(11):1047-56. DOI: 10.1016/j.clinbiochem.2006.07.01010.1016/j.clinbiochem.2006.07.01017005171]Open DOISearch in Google Scholar
[13. Yigitbasi T, Baskin Y, Akgol E, Kocal GC, Ellidokuz H. Association of ischemia-modified albumin with oxidative stress status and insulin resistance in obese patients. Rev Romana Med Lab. 2017;25(3):255-63. DOI: 10.1515/rrlm-2017-002010.1515/rrlm-2017-0020]Open DOISearch in Google Scholar
[14. Sandor R, Leucuta D, Dronca E, Niculae A, Cret V, Silaghi C, et al. Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents. Rev Romana Med Lab. 2015;23(4):385-95. DOI: 10.1515/rrlm-2015-003810.1515/rrlm-2015-0038]Open DOISearch in Google Scholar
[15. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2018 Jan;41(Suppl 1):S1-S151.10.2337/dc18-Sint0129222369]Search in Google Scholar
[16. Cornell S. Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE. J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2):261-265.10.1016/j.japh.2016.11.00528065547]Search in Google Scholar
[17. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyper-glycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015 Jan;38(1):140-9. DOI: 10.2337/dc14-244110.2337/dc14-244125538310]Open DOISearch in Google Scholar
[18. Garvey WT, Ryan DH, Bohannon NJ, Kushner RF, Rueger M, Dvorak RV, et al. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014 Dec;37(12):3309-16. DOI: 10.2337/dc14-093010.2337/dc14-093025249652]Open DOISearch in Google Scholar